Vericel Corporation (VCEL): Price and Financial Metrics
VCEL Price/Volume Stats
| Current price | $57.26 | 52-week high | $57.81 |
| Prev. close | $55.83 | 52-week low | $32.31 |
| Day low | $55.33 | Volume | 335,700 |
| Day high | $57.34 | Avg. volume | 430,364 |
| 50-day MA | $45.61 | Dividend yield | N/A |
| 200-day MA | $46.97 | Market Cap | 2.83B |
VCEL Stock Price Chart Interactive Chart >
Vericel Corporation (VCEL) Company Bio
Vericel Corporation focuses on developing patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. The company was founded in 1989 and is based in Cambridge, Massachusetts.
VCEL Price Returns
| 1-mo | 36.89% |
| 3-mo | 16.17% |
| 6-mo | 18.72% |
| 1-year | 61.34% |
| 3-year | 41.17% |
| 5-year | 208.68% |
| YTD | 60.80% |
| 2023 | 35.19% |
| 2022 | -32.98% |
| 2021 | 27.27% |
| 2020 | 77.47% |
| 2019 | 0.00% |
Continue Researching VCEL
Here are a few links from around the web to help you further your research on Vericel Corp's stock as an investment opportunity:Vericel Corp (VCEL) Stock Price | Nasdaq
Vericel Corp (VCEL) Stock Quote, History and News - Yahoo Finance
Vericel Corp (VCEL) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...